NBY's logo.
Ticker Symbol: NBY

Novabay Pharmaceuticals Inc

$0.51 - 20-11-2024 4 p.m. ET

Exchange: NYSE MKT LLC Country: US Currency: USD Asset Type: Common Stock CIK:0001389545

Company Profile

NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company focusing high-quality, differentiated, anti-infective consumer products: Avenova®, the premier antimicrobial lid and lash spray, CelleRx® Clinical Reset, a breakthrough product in the beauty category, and NeutroPhase® Skin and Wound Cleanser for wound healing. NovaBay's products are formulated with its patented, pure, stable, pharmaceutical-grade hypochlorous acid that replicates the antimicrobial chemicals used by white blood cells to fight infection. NovaBay's hypochlorous acid products do not cause stinging or irritation, are non-toxic and non-sensitizing, making them completely safe for regular use. Avenova is the only commercial hypochlorous acid lid and lash spray product clinically proven to reduce bacterial load on ocular skin surfaces, thus effectively addressing the underlying cause of bacterial dry eye.

Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 2000 Powell St Ste 1150
Website: novabay.com
CEO: Justin Hall
Tags:
  • Health Technology
  • Biotechnology
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

Pricing

Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $0.43
Change: -$0.02 ( -5.42%)
Days Range: $0.43 - $0.45
Beta: 0.59
52wk. High: $4.08
52wk. Low: $0.34
Ytd. Change -82.03%
50 Day Moving Average: $0.47
200 Day Moving Average: $0.77
Shares Outstanding: 4214682

Valuation

Market Cap: 181.8M
PE Ratio: -
EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A